COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis
Abstract Background The SARS-CoV-2 pandemic was a challenge for health care systems worldwide. People with pre-existing chronic diseases have been identified as vulnerable patient groups. Furthermore, some of the drugs used for these chronic diseases such as antihypertensive drugs have been discusse...
Saved in:
| Main Authors: | Roland Linder, Jonas Peltner, Anatoli Astvatsatourov, Willy Gomm, Britta Haenisch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12889-024-21110-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An overview of SARS-COV-2: Virology, Epidemiology, Pathogenesis and Treatment
by: Ramesh Bhandari, et al.
Published: (2020-06-01) -
SARS-COV-2 PREVALENCE IN INDIA COMPARED TO THE REST OF THE GLOBE AND ASCERTAINS EPIDEMIOLOGICAL CHARACTERISTICS ASSOCIATED WITH THE COVID-19 PANDEMIC DURING 2020 IN INDIA
by: M. Rajesh Kumar Rao, et al.
Published: (2023-10-01) -
Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19)
by: Ram Bahadur Khadka, et al.
Published: (2020-04-01) -
Developments in the laboratory diagnosis of SARS — coronavirus infections
by: A.A. Hoosen, et al.
Published: (2005-05-01) -
Clinical and Epidemiological Features of COVID-19 in Children in Moscow in 2020–2022
by: E. R. Samitova
Published: (2022-11-01)